Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Viatris has the lowest figure of the 61 pharmaceutical companies ranked by earnings, at -NOK 34.1B, followed by Insmed (-NOK 12.4B) and Summit Therapeutics (-NOK 10.5B). Figures as of 18 Nov 2026, 19:11 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Viatris-NOK 34.1B
- Median
- NOK 572.1M
- Combined market value
- NOK 49.2T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ViatrisVTRS · Health Care | -NOK 34.1B | NOK 229.2B | NOK 199.89 | 0.81% up | 96% up | ||
| 2 | InsmedINSM · Health Care | -NOK 12.4B | NOK 255.9B | NOK 1,166.54 | 1.28% down | 40% down | ||
| 3 | Summit TherapeuticsSMMT · Health Care | -NOK 10.5B | NOK 81.7B | NOK 102.10 | 1.31% down | 36% down | ||
| 4 | Takeda PharmaceuticalTAK · Health Care | -NOK 9.3B | NOK 661.1B | NOK 206.92 | 1.39% down | 54% up | ||
| 5 | CytokineticsCYTK · Health Care | -NOK 7.6B | NOK 69B | NOK 495.30 | 1.10% down | 20% down | ||
| 6 | BridgeBio PharmaBBIO · Health Care | -NOK 7.1B | NOK 146.9B | NOK 754.15 | 1.27% up | 17% up | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | -NOK 3.7B | NOK 44.9B | NOK 269.66 | 3.15% up | 64% down | ||
| 8 | ABIVAXABVX · Health Care | -NOK 3.6B | NOK 71B | NOK 810.53 | 1.81% up | 27% down | ||
| 9 | Jazz PharmaceuticalsJAZZ · Health Care | -NOK 3.5B | NOK 153.2B | NOK 2,387.38 | 2.28% up | 37% up | ||
| 10 | Cogent BiosciencesCOGT · Health Care | -NOK 3.2B | NOK 47.1B | NOK 270.97 | 0.34% up | 20% down | ||
| 11 | Praxis Precision MedicinesPRAX · Health Care | -NOK 2.9B | NOK 83B | NOK 2,968.68 | 0.36% up | 61% up | ||
| 12 | Roivant SciencesROIV · Health Care | -NOK 2.9B | NOK 269.6B | NOK 372.15 | 0.85% down | 90% up | ||
| 13 | Legend BiotechLEGN · Health Care | -NOK 2.9B | NOK 30.4B | NOK 156.70 | 0.31% up | 42% down | ||
| 14 | Madrigal PharmaceuticalsMDGL · Health Care | -NOK 2.8B | NOK 90.4B | NOK 3,890.09 | 4.93% down | 24% down | ||
| 15 | Ascendis PharmaASND · Health Care | -NOK 2.5B | NOK 172.2B | NOK 2,625.57 | 0.15% down | 28% up | ||
| 16 | Elanco Animal HealthELAN · Health Care | -NOK 2.2B | NOK 130.4B | NOK 260.93 | 4.10% up | 20% up | ||
| 17 | Rhythm PharmaceuticalsRYTM · Health Care | -NOK 1.9B | NOK 80.8B | NOK 1,166.10 | 3.13% up | 13% up | ||
| 18 | Definium TherapeuticsDFTX · Health Care | -NOK 1.8B | NOK 37.9B | NOK 276.84 | 2.83% down | 169% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -NOK 1.8B | NOK 68.2B | NOK 1,295.99 | 1.69% down | 7% down | ||
| 20 | Edgewise TherapeuticsEWTX · Health Care | -NOK 1.6B | NOK 44.1B | NOK 402.99 | 1.14% down | 88% up | ||
| 21 | Dianthus TherapeuticsDNTH · Health Care | -NOK 1.6B | NOK 47.2B | NOK 838.55 | 0.57% down | 113% up | ||
| 22 | Spyre TherapeuticsSYRE · Health Care | -NOK 1.5B | NOK 88.7B | NOK 933.77 | 2.65% up | 286% up | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | -NOK 1.3B | NOK 79.4B | NOK 1,217.01 | 0.67% up | 46% up | ||
| 24 | ErascaERAS · Health Care | -NOK 1.2B | NOK 45.5B | NOK 129.55 | 3.82% down | 403% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -NOK 1B | NOK 62.7B | NOK 924.61 | 1.00% down | 241% up | ||
| 26 | Belite BioBLTE · Health Care | -NOK 752.6M | NOK 61.7B | NOK 1,519.49 | 0.64% down | 31% up | ||
| 27 | VeradermicsMANE · Health Care | -NOK 678.7M | NOK 50.8B | NOK 1,204.89 | 1.10% down | 233% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | -NOK 247.7M | NOK 47.2B | NOK 491.90 | 0.72% down | 44% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | -NOK 226.5M | NOK 58.2B | NOK 890.82 | 0.09% down | 31% up | ||
| 30 | Arrowhead PharmaceuticalsARWR · Health Care | -NOK 15.8M | NOK 59.3B | NOK 419.47 | 0.63% up | 10% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 572.1M | NOK 72.4B | NOK 922.05 | 0.02% down | 126% up | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | NOK 698.7M | NOK 74.2B | NOK 213.08 | 4.05% up | 83% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | NOK 966.3M | NOK 71.9B | NOK 657.33 | 3.25% down | 8% down | ||
| 34 | Ligand PharmaceuticalsLGND · Health Care | NOK 1.2B | NOK 58.3B | NOK 2,916.27 | 2.36% up | 43% up | ||
| 35 | AlkermesALKS · Health Care | NOK 2.3B | NOK 75.9B | NOK 451.57 | 2.46% up | 58% up | ||
| 36 | BeOne MedicinesONC · Health Care | NOK 2.8B | NOK 447.6B | NOK 3,918.75 | 2.21% down | 17% up | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | NOK 3B | NOK 193.8B | NOK 1,446.72 | 4.66% down | 66% down | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | NOK 3.4B | NOK 114.2B | NOK 589.45 | 3.90% up | 11% up | ||
| 39 | GrifolsGRFS · Health Care | NOK 4.3B | NOK 55.6B | NOK 81.69 | 2.38% down | 1% up | ||
| 40 | TG TherapeuticsTGTX · Health Care | NOK 4.3B | NOK 96.5B | NOK 638.52 | 5.01% up | 107% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 4.4B | NOK 121.5B | NOK 145.79 | 1.66% up | 5% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | NOK 6.6B | NOK 48.7B | NOK 583.49 | 0.31% down | 20% down | ||
| 43 | Royalty PharmaRPRX · Health Care | NOK 7.5B | NOK 386.5B | NOK 672.11 | 0.92% up | 78% up | ||
| 44 | GenmabGMAB · Health Care | NOK 9.3B | NOK 306.8B | NOK 497.53 | 1.25% down | 70% up | ||
| 45 | United TherapeuticsUTHR · Health Care | NOK 12.9B | NOK 240B | NOK 5,635.71 | 0.49% down | 23% up | ||
| 46 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 13.7B | NOK 475.9B | NOK 407.88 | 1.30% down | 74% up | ||
| 47 | ZoetisZTS · Health Care | NOK 25.9B | NOK 336.9B | NOK 829.05 | 2.42% up | 29% down | ||
| 48 | Vertex PharmaceuticalsVRTX · Health Care | NOK 38.3B | NOK 1.32T | NOK 5,217.21 | 0.72% up | 27% up | ||
| 49 | AbbVieABBV · Health Care | NOK 41B | NOK 4.92T | NOK 2,781.73 | 2.03% down | 26% up | ||
| 50 | Regeneron PharmaceuticalsREGN · Health Care | NOK 43.7B | NOK 948.1B | NOK 9,165.24 | 1.31% down | 36% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | NOK 63.3B | NOK 1.75T | NOK 1,013.19 | 0.21% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | NOK 68.4B | NOK 1.19T | NOK 581.01 | 2.33% down | 34% up | ||
| 53 | GSKGSK · Health Care | NOK 73.6B | NOK 945.8B | NOK 471.83 | 1.18% down | 6% up | ||
| 54 | PfizerPFE · Health Care | NOK 75.4B | NOK 1.55T | NOK 272.33 | 1.35% down | 14% up | ||
| 55 | SanofiSNY · Health Care | NOK 84.1B | NOK 1.1T | NOK 458.26 | 0.57% down | 4% down | ||
| 56 | AstraZenecaAZN · Health Care | NOK 99.1B | NOK 2.69T | NOK 1,735.24 | 1.82% down | 2% up | ||
| 57 | NovartisNVS · Health Care | NOK 135.6B | NOK 2.85T | NOK 1,508.53 | 2.23% down | 25% up | ||
| 58 | Novo NordiskNVO · Health Care | NOK 147.4B | NOK 1.69T | NOK 383.25 | 2.89% down | 17% down | ||
| 59 | Merck & CoMRK · Health Care | NOK 177B | NOK 3.29T | NOK 1,336.18 | 3.89% down | 51% up | ||
| 60 | Eli LillyLLY · Health Care | NOK 200.1B | NOK 12T | NOK 13,467.97 | 1.88% down | 35% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | NOK 259.9B | NOK 6.4T | NOK 2,659.51 | 1.59% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6965 NOK).
Questions and answers
Which pharmaceutical companies have the lowest earnings?
Viatris (-NOK 34.1B), Insmed (-NOK 12.4B) and Summit Therapeutics (-NOK 10.5B) have the lowest earnings of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 19:11 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of NOK 49.2T as of 18 Nov 2026, 19:11 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.